Corcept Therapeutics earnings (net income)
Corcept Therapeutics (CORT) earned a net income of $99.65 M in fiscal year 2025, −29.4% compared with the year before. Net profit margin: 13.1% of revenue.
Earnings 2025$99.65 M
Change−29.4%
World rank#1125
Market cap$7.42 B
Net income by year
By year
| Year | Value | Change |
|---|---|---|
| 2025 | $99.65 M | −29.4% |
| 2024 | $141.21 M | +33.0% |
| 2023 | $106.14 M | +4.66% |
| 2022 | $101.42 M | — |
Data: company filings via Yahoo Finance, updated 2026-11-19. Not investment advice.